Simultaneously, peroxisome proliferator-activated receptor-γ (PPAR-γ) and TNF-α were downregulated, which ensured enhanced anti-obesity effects. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.